+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Kilitch Drugs to set-up 2nd manufacturing facility in Ethiopia

Dec 9, 2019, 14:30 IST
PTI
New Delhi, Dec 9 () Drug firm Kilitch Drugs on Monday said it will set up its second greenfield facility in Ethiopia to manufacture liquid injectables at an investment of USD 5 million (over Rs 35 crore).

In infrastructure, greenfield projects means those projects where there is no need to remodel or demolish an existing structure.

Advertisement

"Kilitch Drugs, is setting up its second greenfield project in Ethiopia to manufacture liquid injectables and at a capital investment of USD 5 million," the company said in a regulatory filing.

Meanwhile, the company's first manufacturing plant at Addis Ababa has also reached a decisive stage of the completion process, the filing added.

The firm has begun installing machinery at the plant and is scheduled to commence the validation process this month, it noted.

"We are happy to announce our second manufacturing venture in Ethiopia as also for the maiden unit which is now at a very critical stage of our project implementation cycle," Kilitch Drugs Whole time Director Bhavin Mehta said.

Advertisement

Once the validation process is satisfactorily done, Kilitch Drugs plans to commence operations at the first unit in the first quarter of FY 2020-21, Mehta added.

Shares of Kilitch Drugs were trading at Rs 115 per scrip on BSE, down 0.78 per cent from its previous close. AKT DRR

(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)
Next Article